GL0034 (Utreglutide), a novel, long acting, glucagon-like peptide 1 receptor agonist (GLP-1 RA), results of a phase 1 study in healthy individuals

被引:0
|
作者
Thennati, Rajamannar [1 ]
Burade, Vinod [1 ]
Natarajan, Muthukumaran [1 ]
Shahi, Pradeep [1 ]
Nagaraja, Ravishankara [1 ]
Panchal, Satish [1 ]
Agrawal, Sudeep [1 ]
Jandrain, Bernard [2 ]
Duvauchelle, Thierry [3 ]
Pratley, Richard E. [4 ]
Thorens, Bernard [5 ]
Vilsboll, Tina [6 ]
机构
[1] Sun Pharmaceut Ind Ltd, High Impact Innovat Sustainable Hlth Solut HISHS, Vadodara, India
[2] Acad Hosp Liege, ATC Co, Clin Pharmacol Unit, Nutr & Metab Disorders, Liege, Belgium
[3] Phaster1, Paris, France
[4] AdventHlth Translat Res Inst, Orlando, FL USA
[5] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland
[6] Univ Copenhagen, Steno Diabet Ctr, Clin Res, Copenhagen, Denmark
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU-419
引用
收藏
页码:S607 / S608
页数:2
相关论文
共 50 条
  • [31] Effects of tryptophan-selective lipidated glucagon-like peptide 1 (GLP-1) peptides on the GLP-1 receptor
    Lu, Xuejing
    Harada, Norio
    Yasuda, Takuma
    Ikeguchi-Ogura, Eri
    Kobayashi, Daishiro
    Denda, Masaya
    Seno, Yohei
    Yamane, Shunsuke
    Yabe, Daisuke
    Otaka, Akira
    Inagaki, Nobuya
    JOURNAL OF ENDOCRINOLOGY, 2025, 264 (03)
  • [32] Splenic Artery Thrombosis and Glucagon-like Peptide-1 (GLP-1) Agonist: Is There an Association?
    Lee, Regis
    Alukal, Joseph J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2966 - S2967
  • [33] Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
    Ja'arah, Daria
    Al Zoubi, Mazhar Salim
    Abdelhady, Gamal
    Rabi, Firas
    Tambuwala, Murtaza M.
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2021, 14
  • [34] Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders
    Wroge, Jamie
    Williams, Nancy Toedter
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (12) : 1041 - 1050
  • [35] Long-Acting Glucagon-Like Peptide-1 (GLP-1) Agonist Therapy in Post Solid Organ Transplant Patients.
    Krisl, J.
    Gaber, A.
    Sadhu, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 523 - 524
  • [36] Glucagon-like peptide-1 receptor agonist (GLP1-RA) therapy in type 2 diabetes
    Ng, Elisabeth
    Shaw, Jonathan E.
    Wood, Anna
    Maple-Brown, Louise J.
    Hare, Matthew J. L.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2022, 51 (07) : 513 - 518
  • [37] Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists
    Evers, Andreas
    Haack, Torsten
    Lorenz, Martin
    Bossart, Martin
    Elvert, Ralf
    Henkel, Bernd
    Stengelin, Siegfried
    Kurz, Michael
    Glien, Maike
    Dudda, Angela
    Lorenz, Katrin
    Kadereit, Dieter
    Wagner, Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (10) : 4293 - 4303
  • [38] Discovery of novel OXM-based glucagon-like peptide 1 (GLP-1)/glucagon receptor dual agonists
    Zhang, Xiaolong
    Cai, Yuchen
    Yao, Zhihong
    Chi, Heng
    Li, Yan
    Shi, Jingjing
    Zhou, Zhongbo
    Sun, Lidan
    PEPTIDES, 2023, 161
  • [39] Long-Acting Glucagon-Like Peptide-1 (GLP-1) Agonist Therapy in Post Solid Organ Transplant Patients.
    Krisl, J.
    Gaber, A.
    Sadhu, A.
    TRANSPLANTATION, 2014, 98 : 523 - 524
  • [40] Description and application of a novel glucagon-like peptide-1 (GLP-1) radioimmunoassay
    Lelesz, B.
    Toth, G. K.
    Peitl, B.
    Hegedus, C.
    Drimba, L.
    Sari, R.
    Szilvassy, Z.
    Nemeth, J.
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2014, 299 (01) : 157 - 164